| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 01/11/2006 | EP1613637A1 Process for the production of imidazopyridin-8-ones |
| 01/11/2006 | EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 01/11/2006 | EP1613627A1 7-azaindoles and use thereof as therapeutic agents |
| 01/11/2006 | EP1613626A1 Cyclic benzimidazoles |
| 01/11/2006 | EP1613625A1 Novel fused triazolones and the uses thereof |
| 01/11/2006 | EP1613615A2 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 01/11/2006 | EP1613613A2 Cxcr4 chemokine receptor binding compounds |
| 01/11/2006 | EP1613601A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists |
| 01/11/2006 | EP1613368A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 01/11/2006 | EP1613322A2 Aminoquinoline compounds |
| 01/11/2006 | EP1613318A2 Compounds and their use to treat diabetes and related disorders |
| 01/11/2006 | EP1613313A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 01/11/2006 | EP1525202B1 Novel 2,5-disubstituted pyrimidine derivatives |
| 01/11/2006 | EP0930883B1 Neurotrophin antagonists for the treatment of epilepsy, alzheimer's disease and pain |
| 01/11/2006 | EP0859610B1 Ibogamine congeners |
| 01/11/2006 | CN1720228A Process for making risperidone and intermediates therefor |
| 01/11/2006 | CN1720224A Vasculostatic agents and methods of use thereof |
| 01/11/2006 | CN1720047A PgD2 receptor antagonists for the treatment of inflammatory diseases |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235882C Aliphatic amino substituted indole quinoline derivatives, their preparation method and pharmaceutical application |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984646 suitable for the preparation of medicaments for the treatment of diseases associated with p38 MAP kinase such as atherosclerosis, diabetes, adult respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, fever etc |
| 01/10/2006 | US6984642 for treating cardiovascular disorders, for example for the acute and chronic treatment of ischaemic disorders |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | US6984462 Organic electroluminescent devices using double-spiro organic compounds |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2383332C Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 01/10/2006 | CA2381513C Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
| 01/10/2006 | CA2370411C Diazabicyclo compounds for the treatment of schizophrenia and other disorders |
| 01/10/2006 | CA2268157C Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
| 01/10/2006 | CA2223918C Pyrrole derivatives and medicinal composition |
| 01/05/2006 | WO2006002102A2 Spirocyclic compounds useful as modulators of nuclear hormone receptor function |
| 01/05/2006 | WO2006001894A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/05/2006 | WO2006001754A1 New derivatives of 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxamide or 5-aryl-1h-pyrrolo [2, 3b] pyridine-3-carboxylic acid |
| 01/05/2006 | WO2006001750A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 01/05/2006 | WO2006001511A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 01/05/2006 | WO2006001501A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists |
| 01/05/2006 | WO2006000914A1 Diazabicyclic histamine-3 receptor antagonists |
| 01/05/2006 | WO2005113553A3 Azinyl imidazoazine and azinyl carboxamide |
| 01/05/2006 | WO2005100352A8 Selected cgrp-antagonists, their preparation processes and their use as medicaments |
| 01/05/2006 | WO2005097796A3 Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxy}ethyl}-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
| 01/05/2006 | WO2005092335B1 TETRAHYDRO-β-CARBOLINE COMPOUNDS AND USE THEREOF |
| 01/05/2006 | WO2005085194A3 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors |
| 01/05/2006 | WO2004092167A8 Beta-carbolines useful for treating inflammatory disease |
| 01/05/2006 | WO2004091504A3 Substituted quinobenzoxazine analogs |
| 01/05/2006 | WO2004080976A8 Phthalazinone derivatives |
| 01/05/2006 | US20060004428 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
| 01/05/2006 | US20060004203 Modified pictet-spengler reaction and products prepared therefrom |
| 01/05/2006 | US20060004202 Process for the preparation of Imiquimod |
| 01/05/2006 | US20060004201 White organic fluorescent compound |
| 01/05/2006 | US20060004188 Chemically reactive carbocyanine dyes incorporating an indolium ring moiety that is substituted at the 3-position by a reactive group or by a conjugated substance |
| 01/05/2006 | US20060004041 Compounds for treatment of neurodegenerative diseases |
| 01/05/2006 | US20060004039 Aryl-substituted benzimidazole and imidazopyridine ethers |
| 01/05/2006 | US20060004034 Treating conditions associated with the nociceptin/ORL1 receptor system, e.g. pain, drug withdrawal, anxiety, muscle relaxants, anxiolytic agents; e.g. 1,1-[3-dimethylamino-3-(pyridin-2-yl)pentamethylene]-3,4-dihydro-1H-2,9-diazafluorene |
| 01/05/2006 | US20060004028 Novel PARP inhibitor |
| 01/05/2006 | US20060004024 Reacting 2,4-difluorophenyl (4-piperidinyl) methanone oxime hydrochloride and 3-(2-haloethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one in an aqueous alkali solution: high yeild when alkali hydroxide concentration is in the range of 20 to 40% |
| 01/05/2006 | US20060004021 Ethyl 4-{[2-(3-chlorophenyl)-2H-tetrazol-5-yl]methyl}piperazine-1-carboxylate; gastrointestinal disorders, chronic and acute pain, psychiatric and neurological disorders; obesity |
| 01/05/2006 | US20060004017 Quinazoline derivatives as angiogenesis inhibitors |
| 01/05/2006 | US20060004008 Topoisomerase inhibitors; useful as antibacterial, antifungal agents; cancer; structure is based on substituted benzo(i)phenanthridine ring where the ring carbon atoms at position 5 and 11 are optionally replaced by nitrogen |
| 01/05/2006 | US20060004006 Pyrrolotriazine kinase inhibitors |
| 01/05/2006 | US20060004004 Novel gamma secretase inhibitors |
| 01/05/2006 | US20060004003 e.g. 1-Ethyl-4-(5-methyl-3-pyridyl)-6-phenyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid; phosphodiesterase (PDE)-IV inhibitor or tumor necrosis factor (TNF)- alpha antagonist; autoimmune diseases, antidepressant, anxiolytic agent; polychondritis, scleroderma, fibrosis, arthritis, Alzheimer's disease |
| 01/05/2006 | US20060004000 N-aryl-5-substituted-3-yl-1H-indazole-3-carboxamides; amidation of the 1-protected-1H-indazole-3-carboxylic acid, deblocking; hypotensive agents |
| 01/05/2006 | US20060003987 Compounds and their uses |
| 01/05/2006 | US20060003968 allergies, proliferative diseases, autoimmune diseases, bone disorders; pyrrolo[2,3-b]pyridine derivatives |
| 01/05/2006 | DE102004024453A1 Neue langwirksame Bronchodilatoren zur Behandlung von Atemwegserkrankungen New long-acting bronchodilators for the treatment of respiratory disorders |
| 01/05/2006 | CA2571555A1 Diazabicyclic histamine-3 receptor antagonists |
| 01/05/2006 | CA2571058A1 Cannabinoid receptor ligands |
| 01/05/2006 | CA2571012A1 Tricyclic compounds and their use as mglur1 antagonists |
| 01/05/2006 | CA2570619A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 01/05/2006 | CA2568804A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as crf antagonists |
| 01/05/2006 | CA2568802A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with tetrahydropyridine as crf antagonists |
| 01/05/2006 | CA2567977A1 Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
| 01/04/2006 | EP1612273A1 Novel physiologically active substances pf1270a, b and c |
| 01/04/2006 | EP1611134A1 Beta-carbolines useful for treating inflammatory disease |
| 01/04/2006 | EP1611133A1 Condensed n-heterocyclic compounds and their use as crf receptor antagonists |
| 01/04/2006 | EP1611132A1 Substituted pyrroline kinase inhibitors |
| 01/04/2006 | EP1611131A1 Pyrazolopyridine derivates |
| 01/04/2006 | EP1611130A2 Reverse-turn mimetics and method relating thereto |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610795A2 Heterocyclic substituted 1,4-dihydro-4-oxo-1,8-naphthpyridine analogs |
| 01/04/2006 | EP1610759A2 Substituted quinobenzoxazine analogs |
| 01/04/2006 | EP1395585B1 Antibacterial agents |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1294725B1 Multicyclic compounds and their use as inhibitors of parp, vegfr2 and mlk3 enzymes |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | EP0934288B1 Oxadiazoles, processes for their preparation and their use as medicaments |
| 01/04/2006 | CN1717409A Pyrazolonaphthyridine derivative |
| 01/04/2006 | CN1717403A Process for preparing optically pure active compounds |
| 01/04/2006 | CN1717401A Anilinopyrazole derivatives useful for the treatment of diabetes |
| 01/04/2006 | CN1715280A Aryl fused azapolycyclic compounds |
| 01/04/2006 | CN1234693C Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 01/03/2006 | US6982333 Intermediates in the synthesis of camptothecin and related compounds and synthesis thereof |
| 01/03/2006 | US6982271 selective norepinephrine and serotonin reuptake inhibitor (SSNRI); antidepressant; treating cocaine addiction; "N3 bridged" tropanes |
| 01/03/2006 | CA2187146C 8-arylalkyl- and 8-arylheteroalkyl-5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e]-[1,4]- diazepines and their use in the prevention or treatment of hiv infection |
| 01/03/2006 | CA2185350C Acridone-derived bisintercalators as chemotherapeutic agents |